How Did Biotech and Healthcare Stocks Perform During This 2 Day Trading Rally?…Update-2 earnings deliver!

Update-2 4/26..ABBVIe (ABV) beats on sales and earnings but Humira revenue concerns linger stock down 4+%.  SMID caps up: CRMD,CYRX, GERN,SUPN, TXG etc....XBI up 1.5% after dipping to $81 . Update-1 4/25...MRK up over 3% on confirmed guidance Revs at $63-64B,EPS $8.53-8.65, Junuvia drug on...

Pin It on Pinterest